Vascular Endothelial Growth Factor Molecular and Biological Aspects

Advances in Organ Biology

Volumn 7, Issue C, 1999, Pages 25-57

  Ferrara, Napoleone ^a   Gerber, Hans Peter ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77956802838     PISSN: 15692590     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1569-2590(08)60162-7     Document Type: Article

References (211)

1. Adamis A.P., Miller J.W., Bernal M.T., D'Amico D.J., Folkman J., Yeo T.K., and Yeo K.T. Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am. J. Ophthalmol. 118 (1994) 445-450
2. Adamis A.P., Shima D.T., Tolentino M.J., Gragoudas E.S., Ferrara N., Folkman J., D'Amore P.A., and Miller J.W. Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate. Arch. Ophthalmol. 114 (1996) 66-71
3. Aiello L.P., Avery R.L., Arrigg P.G., Keyt B.A., Jampel H.D., Shah S.T., Pasquale L.R., Thieme H., Iwamoto M.A., Park J.E., Nguyen H., Aiello L.M., Ferrara N., and King G.L. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N. Engl. J. Med. 331 (1994) 1480-1487
4. Aiello L.P., Pierce E.A., Foley E.D., Takagi H., Chen H., Riddle L., Ferrara N., King G.L., and Smith L.E. Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 10457-10461
5. Albini A., Benelli R., Presta M., Rusnati M., Ziche M., Rubartelli A., Paglialunga G., Bussolino F., and Noonan D. HIV-tat protein is a heparin-binding angiogenic growth factor. Oncogene 12 (1996) 289-297
6. Albini A., Soldi R., Giunciuglio D., Giraudo E., Benelli R., Primo L., Noonan D., Salio M., Camussi G., Rockl W., and Bussolino F. The angiogenesis induced by HIV-1 tat protein is mediated by the Flk-1/KDR receptor on vascular endothelial cells. Nature Med. 2 (1996) 1371-1375
7. Algire G.H., and Chalkley H.W. Vascular reactions of normal and malignant tissues in vivo. I. Vascular recations of mice to wounds and to normal and neoplastic transplants. J. Natl. Cancer Inst. 6 (1945) 73-85
8. Alon T., Hemo I., Itin A., Pe'er J., Stone J., and Keshet E. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nature Med. 1 (1995) 1024-1028
9. Asahara T., Bauters C., Pastore C., Kearney M., Rossow S., Bunting S., Ferrara N., Symes J.F., and Isner J.M. Local delivery of vascular endothelial growth factor accelerates reendothelialization and attenuates intimal hyperplasia in balloon-injured rat carotid artery. Circulation 91 (1995) 2793-2801
10. Asano M., Yukita A., Matsumoto T., Kondo S., and Suzuki H. Inhibition of tumor growth and metastasis by an immunoneutralizing monoclonal antibody to human vascular endothelial growth factor/vascular permeability factor121. Cancer Res. 55 (1995) 5296-5301
11. Banai S., Jaktlish M.T., Shou M., Lazarous D., Scheinowitz M., Biro S., Epstein S., and Unger E. Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor. Circulation (1994) 2183-2189
12. Banai S., Shweiki D., Pinson A., Chandra M., Lazarovich G., and Keshet E. Upregulation of vascular endothelial growth factor expression induced by myocardial ischemia: Implications for coronary angiogenesis. Cardiovasc. Res. 28 (1994) 1176-1179
13. Barleon B., Sozzani S., Zhou D., Weich H.A., Mantovani A., and Marme D. Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood 87 (1996) 3336-3343
14. Bauters C., Asahara T., Zheng L.P., Takeshita S., Bunting S., Ferrara N., Symes J.F., and Isner J.M. Physiological assessment of augmented vascularity induced by VEGF in ischemic rabbit hindlimb. Am. J. Physiol. 267 (1994) H1263-H1271
15. Bauters C., Asahara T., Zheng L.P., Takeshita S., Bunting S., Ferrara N., Symes J.F., and Isner J.M. Recovery of disturbed endothelium-dependent flow in the collateral-perfused rabbit ischemic hindlimb after administration of vascular endothelial growth factor. Circulation 91 (1995) 2802-2809
16. Ben-Av P., Crofford L.J., Wilder R.L., and Hla T. Induction of vascular endothelial growth factor expression in synovial fibroblasts. FEBS Letters 372 (1995) 83-87
17. Berkman R.A., Merrill M.J., Reinhold W.C., Monacci W.T., Saxena A., Clark W.C., Robertson J.T., Ali I.U., and Oldfield E.H. Expression of the vascular permeability factor/vascular endothelial growth factor gene in central nervous system neoplasms. J. Clin. Invest. 91 (1993) 153-159
18. Bikfalvi A., Klein S., Pintucci G., and Rifkin D.B. Biological roles of fibroblast growth factor-2. Endocr. Rev. 18 (1997) 26-45
19. Borgström P., Hillan K.J., Sriramarao P., and Ferrara N. Complete inhibition of angiogenesis and growth of microtumors by anti-vascular endothelial growth factor neutralizing antibody: novel concepts of angiostatic therapy from intravital videomicroscopy. Cancer Res. 56 (1996) 4032-4039
20. Borgström P., Hillan K., Sriramarao P., and Ferrara N. Anti-Vascular endothelial growth factor antibody inhibits angiogenesis and growth of human prostate cancer in vivo. Prostate 1 (1998) 1-10
21. Borgström, P., Hillan, K.J., Sriraramao, P. and Ferrara, N. Combination treatment with anti-vascular endothelial growth factor antibody and doxorubicin suppresses growth of breast carcinoma cells. Submitted for publication.
22. Brandon E.P., Idzerda R.L., and McKnight G.S. Targeting the mouse genome: a compendium of knockouts (part III). Curr. Biol. 5 (1995) 873-881
23. Breier G., Albrecht U., Sterrer S., and Risau W. Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation. Development 114 (1992) 521-532
24. Brogi E., Schatteman G., Wu T., Kim E.A., Varticovski L., Keyt B., and Isner J.M. Hypoxia-induced paracrine regulation of vascular endothelial growth factor receptor expression. J. Clin. Invest. 97 (1996) 469-476
25. Brown L.F., Berse B., Jackman R.W., Tognazzi K., Guidi A.J., Dvorak H.F., Senger D.R., Connolly J.L., and Schnitt S.J. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer. Hum. Pathol. 26 (1995) 86-91
26. Brown L.F., Berse B., Jackman R.W., Tognazzi K., Manseau E.J., Dvorak H.F., and Senger D.R. Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas. Am. J. Pathol. 143 (1993) 1255-1262
27. Brown L.F., Berse B., Jackman R.W., Tognazzi K., Manseau E.J., Senger D.R., and Dvorak H.F. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract. Cancer Res. 53 (1993) 4727-4735
28. Brown L.F., Harrist T.J., Yeo K.T., Stahle-Backdahl M., Jackman R.W., Berse B., Tognazzi K., Dvorak H.F., and Detmar M. Increased expression of vascular permeability factor (vascular endothelial growth factor) in bullous pemphigoid, dermatitis herpetiformis, and erythema multiforme. J. Invest. Dermatol. 104 (1995) 744-749
29. Broxmeyer H.E., Cooper S., Li Z.H., Lu L., Song H.Y., Kwon B.S., Warren R.E., and Donner D.B. Myeloid progenitor cell regulatory effects of vascular endothelial cell growth factor. Int. J. Hematol. 62 (1995) 203-215
30. Callow A.D., Choi E.T., Trachtenberg J.D., Stevens S.L., Connolly D.T., Rodi C., and Ryan U.S. Vascular permeability factor accelerates endothelial regrowth following balloon angioplasty. Growth Factors 10 (1994) 223-228
31. Cao Y., Chen H., Zhou L., Chiang M.K., Anand Apte B., Weatherbee J.A., Wang Y., Fang F., Flanagan J.G., and Tsang M.L. Heterodimers of placenta growth factor/vascular endothelial growth factor. Endothelial activity, tumor cell expression, and high affinity binding to Flk-1/KDR. J. Biol. Chem. 271 (1996) 3154-3162
32. Carmeliet P., Ferreira V., Breier G., Pollefeyt S., Kieckens L., Gertsenstein M., Fahrig M., Vandenhoeck A., Harpal K., Eberhardt C., Declercq C., Pawling J., Moons L., Collen D., Risau W., and Nagy A. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380 (1996) 435-439
33. Claffey K.P., Wilkison W.O., and Spiegelman B.M. Vascular endothelial growth factor. Regulation by cell differentiation and activated second messenger pathways. J. Biol. Chem. 267 (1992) 16317-16322
34. Clapp C., and de la Escalera G.M. Prolactins: Novel regulators of ongiogenesis. News Physiol. Sci. 12 (1997) 231-237
35. Clauss M., Gerlach M., Gerlach H., Brett J., Wang F., Familletti P.C., Pan Y.C., Olander J.V., Connolly D.T., and Stern D. Vascular permeability factor: A tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration. J. Exp. Med. 172 (1990) 1535-1545
36. Cohen T., Nahari D., Cerem L.W., Neufeld G., and Levi B.Z. Interleukin 6 induces the expression of vascular endothelial growth factor. J. Biol. Chem. 271 (1996) 736-741
37. Conn G., Bayne M.L., Soderman D.D., Kwok P.W., Sullivan K.A., Palisi T.M., Hope D.A., and Thomas K.A. Amino acid and cDNA sequences of a vascular endothelial cell mitogen that is homologous to platelet-derived growth factor. Proc. Natl. Acad. Sci. U.S.A. 87 (1990) 2628-2632
38. Cuevas P., Carceller F., Ortega S., Zazo M., Nieto I., and Gimenez-Gallego G. Hypotensive activity of fibroblast growth factor. Science 254 (1991) 1208-1210
39. Cuevas P., Garcia-Calvo M., Carceller F., Reimers D., Zazo M., Cuevas B., Munoz-Willery I., Martinez-Coso V., Lamas S., and Gimenez-Gallego G. Correction of hypertension by normalization of endothelial levels of fibroblast growth factor and nitric oxide synthase in spontaneously hypertensive rats. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 11996-12001
40. Cullinan-Bove K., and Koos R.D. Vascular endothelial growth factor/vascular permeability factor expression in the rat uterus: Rapid stimulation by estrogen correlates with estrogen-induced increases in uterine capillary permeability and growth. Endocrinology 133 (1993) 829-837
41. Cunningham S.A., Waxham M.N., Arrate P.M., and Brock T.A. Interaction of the Flt-1 tyrosine kinase receptor with the p85 subunit of phosphatidylinositol 3-kinase. Mapping of a novel site involved in binding. J. Biol. Chem. 270 (1995) 20254-20257
42. Davis S., Aldrich T.H., Jones P.F., Acheson A., Compton D.L., Jain V., Ryan T.E., Bruno J., Radziejewski C., Maisonpierre P.C., and Yancopoulos G.D. Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell 87 (1996) 1161-1169
43. Davis-Smyth T., Chen H., Park J., Presta L.G., and Ferrara N. The second immunoglobulin-like domain of the VEGF tyrosine kinase receptor Flt-1 determines ligand binding and may initiate a signal transduction cascade. EMBO J. 15 (1996) 4919-4927
44. de Vries C., Escobedo J.A., Ueno H., Houck K., Ferrara N., and Williams L.T. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 255 (1992) 989-991
45. Detmar M., Brown L.F., Claffey K.P., Yeo K.T., Kocher O., Jackman R.W., Berse B., and Dvorak H.F. Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis. J. Exp. Med. 180 (1994) 1141-1146
46. DiPietro L.A. Thrombospondin as a regulator of angiogenesis. In: Rosen E., and Goldberg I.D. (Eds). Regulation of angiogenesis (1997), Springer Verlag, New York 295-314
47. DiSalvo J., Bayne M.L., Conn G., Kwok P.W., Trivedi P.G., Soderman D.D., Palisi T.M., Sullivan K.A., and Thomas K.A. Purification and characterization of a naturally occurring vascular endothelial growth factor/placenta growth factor heterodimer. J. Biol. Chem. 270 (1995) 7717-7723
48. Dvorak H.F. Tumors: Wounds that do not heal. Similarities between tumor stroma generation and wound healing. N. Engl. J. Med. 315 (1986) 1650-1659
49. Dvorak H.F., Brown L.F., Detmar M., and Dvorak A.M. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am. J. Pathol. 146 (1995) 1029-1039
50. Dvorak H.F., Harvey V.S., Estrella P., Brown L.F., McDonagh J., and Dvorak A.M. Fibrin containing gels induce angiogenesis. Implications for tumor stroma generation and wound healing. Lab. Invest. 57 (1987) 673-686
51. Essed C.D., Brand M.V.D., and Becker A.E. Transluminal coronary angioplasty and early restenosis. Brit. Heart J. 49 (1983) 393-402
52. Fassbender H.J., and Simling-Annenfeld M. The potential aggressiveness of synovial tissue in rheumatoid arthritis. J. Pathol. 10 (1983) 845-851
53. Fava R.A., Olsen N.J., Spencer-Green G., Yeo K.T., Yeo T.K., Berse B., Jackman R.W., Senger D.R., Dvorak H.F., and Brown L.F. Vascular permeability factor/endothelial growth factor (VPF/VEGF): Accumulation and expression in human synovial fluids and rheumatoid synovial tissue. J. Exp. Med. 180 (1994) 341-346
54. Ferrara N., Carver Moore K., Chen H., Dowd M., Lu L., O'Shea K.S., Powell Braxton L., Hillan K.J., and Moore M.W. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380 (1996) 439-442
55. Ferrara N., Clapp C., and Weiner R. The 16K fragment of prolactin specifically inhibits basal or fibroblast growth factor stimulated growth of capillary endothelial cells. Endocr. 129 (1991) 896-900
56. Ferrara N., and Davis-Smyth T. The Biology of Vascular Endothelial Growth Factor. Endocr. Rev. 18 (1997) 4-25
57. Ferrara N., and Henzel W.J. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem. Biophys. Res. Commun. 161 (1989) 851-858
58. Ferrara N., Houck K., Jakeman L., and Leung D.W. Molecular and biological properties of the vascular endothelial growth facmily of proteins. Endocr. Rev. (1992) 18-32
59. Ferrara N., Winer J., Burton T., Rowland A., Siegel M., Phillips H.S., Terrell T., Keller G.A., and Levinson A.D. Expression of vascular endothelial growth factor does not promote transformation but confers a growth advantage in vivo to Chinese hamster ovary cells. J. Clin. Invest. 91 (1993) 160-170
60. Finnerty H., Kelleher K., Morris G.E., Bean K., Merberg D.M., Kriz R., Morris J.C., Sookdeo H., Turner K.J., and Wood C.R. Molecular cloning of murine FLT and FLT4. Oncogene 8 (1993) 2293-2298
61. Folkman J. Tumor angiogenesis: therapeutic implications. N. Engl. J. Med. 285 (1971) 1182-1186
62. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Med. 1 (1995) 27-31
63. Folkman J., and Shing Y. Angiogenesis. J. Biol. Chem. 267 (1992) 10931-10934
64. Fong G.H., Rossant J., Gertsenstein M., and Breitman M.L. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 376 (1995) 66-70
65. Forsythe J.A., Jiang B.H., Iyer N.V., Agani F., Leung S.W., Koos R.D., and Semenza G.L. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol. Cell. Biol. 16 (1996) 4604-4613
66. Frank S., Hubner G., Breier G., Longaker M.T., Greenhalg D.G., and Werner S. Regulation of VEGF expression in cultured keratinocytes. Implications for normal and impaited wound healing. J. Biol. Chem. 270 (1995) 12607-12613
67. Friedlander M., Brooks P.C., Shaffer R.W., Kincaid C.M., Varner J.A., and Cheresh D.A. Definition of two angiogenic pathways by distinct alpha v integrins. Science 270 (1995) 1500-1502
68. Gabrilovich D.I., Chen H.L., Girgis K.R., Cunningham H.T., Meny G.M., Nadaf S., Kavanaugh D., and Carbone D.P. Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells. Nature Med. 2 (1996) 1096-1103
69. Galland F., Karamysheva A., Mattei M.G., Rosnet O., Marchetto S., and Birnbaum D. Chromosomal localization of FLT4, a novel receptor-type tyrosine kinase gene. Genomics 13 (1992) 475-478
70. Garner A. Vascular diseases. In: Garner A., and Klintworth G.K. (Eds). Pathobiology of Ocular Disease (1994), Marcel Dekker, New York
71. Gasparini G., Toi M., Gion M., Verderio P., Dittadi R., Hanatani M., Matsubara I., Vinante O., Bonoldi E., Boracchi P., Gatti C., Suzuki H., and Tominaga T. Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma. J. Natl. Cancer Inst. 89 (1997) 139-147
72. Gerber H.P., Condorelli F., Park J., and Ferrara N. Differential transcriptional regulation of the two VEGF receptor genes. Flt-1, but not Flk-1/KDR, is up-regulated by hypoxia. J. Biol. Chem. 272 (1997) 23659-23667
73. Goldberg M.A., and Schneider T.J. Similarities between the oxygen-sensing mechanisms regulating the expression of vascular endothelial growth factor and erythropoietin. J. Biol. Chem. 269 (1994) 4355-4361
74. Goldman C., Kim J., Wonf W.-L., King V., Brock T., and Gillespie Y. Epidermal growth factor stimulates vascular endothelial growth factor production by malignant glioma cells. A model of glioblastoma multiforme pathophysiology. Molec. Biol. Cell 4 (1993) 121-133
75. Good D., Polverini P., Rastinejad F., Beau M., Lemons R., Frazier W., and Bouck N. A tumor suppressor-dependent inhibition of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. Proc. Natl. Acad. Sci. U.S.A. 87 (1990) 6624-6628
76. Graor R.A., and Gray B.H. Interventional treatment of peripheral vascular disease. In: Young J.R., Graor R.A., Olin J.W., and Bartholomew J.R. (Eds). Peripheral Vascular Diseases (1991), Mosby, St. Louis
77. Grugel S., Finkenzeller G., Weindel K., Barleon B., and Marme D. Both v-Ha-Ras and v-Raf stimulate expression of the vascular endothelial growth factor in NIH 3T3 cells. J. Biol. Chem. 270 (1995) 25915-25919
78. Guidi A.J., Abu-Jawdeh G., Berse B., Jackman R.W., Tognazzi K., Dvorak H.F., and Brown L.F. Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in cervical neoplasia. J. Natl. Cancer Inst. 87 (1995) 1237-1245
79. Guidi A.J., Abu Jawdeh G., Tognazzi K., Dvorak H.F., and Brown L.F. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in endometrial carcinoma. Cancer 78 (1996) 454-460
80. Guo D., Jia Q., Song H.Y., Warren R.S., and Donner D.B. Vascular endothelial cell growth factor promotes tyrosine phosphorylation of mediators of signal transduction that contain SH2 domains. Association with endothelial cell proliferation. J. Biol. Chem. 270 (1995) 6729-6733
81. Harada K., Friedman M., Lopez J.J., Wang S.Y., Li J., Prasad P.V., Pearlman J.D., Edelman E.R., Sellke F.W., and Simons M. Vascular endothelial growth factor administration in chronic myocardial ischemia. Am. J. Physiol. 270 (1996) H1791-H1802
82. Hashimoto E., Ogita T., Nakaoka T., Matsuoka R., Takao A., and Kira Y. Rapid induction of vascular endothelial growth factor expression by transient ischemia in rat heart. Am. J. Physiol. 267 (1994) H1948-H1954
83. Hashimoto M., Ohsawa M., Ohnishi A., Naka N., Hirota S., Kitamura Y., and Aozasa K. Expression of vascular endothelial growth factor and its receptor mRNA in angiosarcoma. Lab. Invest. 73 (1995) 859-863
84. Houck K.A., Ferrara N., Winer J., Cachianes G., Li B., and Leung D.W. The vascular endothelial growth factor family: Identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol. Endocr. 5 (1991) 1806-1814
85. Houck K.A., Leung D.W., Rowland A.M., Winer J., and Ferrara N. Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. J. Biol. Chem. 267 (1992) 26031-26037
86. Ikeda E., Achen M.G., Breier G., and Risau W. Hypoxia-induced transcriptional activation and increased mRNA stability of vascular endothelial growth factor in C6 glioma cells. J. Biol. Chem. 270 (1995) 19761-19766
87. Iliopoulos O., Levy A.P., Jiang C., Kaelin Jr. W.G., and Goldberg M.A. Negative regulation of hypoxia-inducible genes by the von Hippel---Lindau protein. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 10595-10599
88. Isner J.M., Pieczek A., Schainfeld R., Blair R., Haley L., Asahara T., Rosenfield K., Razvi S., Walsh K., and Symes J.F. Clinical evidence of angiogenesis after arterial gene transfer of ph VEGF165 in patient with ischaemic limb. Lancet 348 (1996) 370-374
89. Isner J.M., Walsh K., Symes J., Picczek A., Takeshita S., Lowry J., Rosenfield K., Weir L., Brogi E., and Jurayj D. Arterial gene transfer for therapeutic angiogenesis in patients with peripheral artery disease. Hum. Gene Ther. 7 (1996) 959-988
90. Jakeman L.B., Armanini M., Philips H.S., and Ferrara N. Developmental expression of binding sites and mRNA for vascular endothelial growth factor suggests a role for this protein in vasculogenesis and angiogenesis. Endocrinology 133 (1993) 848-859
91. Jakeman L.B., Winer J., Bennett G.L., Altar C.A., and Ferrara N. Binding sites for vascular endothelial growth factor are localized on endothelial cells in adult rat tissues. J. Clin. Invest. 89 (1992) 244-253
92. Jeltsch M., Kaipainen A., Joukov V., Meng X., Lakso M., Rauvala H., Awartz M., Fukumura D., Jain R.K., and Alitalo K. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science 276 (1997) 1423-1425
93. Joukov V., Pajusola K., Kaipainen A., Chilov D., Lahtinen I., Kukk E., Saksela O., Kalkkinen N., and Alitalo K. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J. 15 (1996) 1751-1758
94. Kaipainen A., Korhonen J., Mustonen T., van Hinsbergh V.W., Fang G.H., Dumont D., Breitman M., and Alitalo K. Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 3566-3570
95. Kamat B.R., Brown L.F., Manseau E.J., Senger D.R., and Dvorak H.F. Expression of vascular permeability factor/vascular endothelial growth factor by human granulosa and theca lutein cells. Role in corpus luteum development. Am. J. Pathol. 146 (1995) 157-165
96. Kendall R.L., Wang G., and Thomas K.A. Identification of a natural soluble form of the vascular endothelial growth factor receptor, FLT-1, and its heterodimerization with KDR. Biochem. Biophys. Res. Commun. 226 (1996) 324-328
97. Keyt B.A., Berleau L.T., Nguyen H.V., Chen H., Heinsohn H., Vandlen R., and Ferrara N. The carboxyl-terminal domain (111--165) of vascular endothelial growth factor is critical for its mitogenic potency. J. Biol. Chem. 271 (1996) 7788-7795
98. Keyt B.A., Nguyen H.V., Berleau L.T., Duarte C.M., Park J., Chen H., and Ferrara N. Identification of vascular endothelial growth factor determinants for binding KDR and FLT-1 receptors. Generation of receptor-selective VEGF variants by site-directed mutagenesis. J. Biol. Chem. 271 (1996) 5638-5646
99. Kieser A., Weich H., Brandner G., Marme D., and Kolch W. Mutant p53 potentiates protein kinase C induction of vascular endothelial growth factor expression. Oncogene 9 (1994) 963-969
100. Kim K.J., Li B., Houck K., Winer J., and Ferrara N. The vascular endothelial growth factor proteins: Identification of biologically relevant regions by neutralizing monoclonal antibodies. Growth Factors 7 (1992) 53-64
101. Kim K.J., Li B., Winer J., Armanini M., Gillett N., Phillips H.S., and Ferrara N. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo. Nature 362 (1993) 841-844
102. Koch A.E., Harlow L., Haines G.K., Amento E.P., Unemori E.N., Wong W.-L., Pope R.M., and Ferrara N. Vascular endothelial growth factor: A cytokine modulating endothelial function in rheumatoid arthritis. J. Immunol. 152 (1994) 4149-4156
103. Kondo S., Asano M., Matsuo K., Ohmori I., and Suzuki H. Vascular endothelial growth factor/vascular permeability factor is detectable in the sera of tumor-bearing mice and cancer patients. Biochim. Biophys. Acta 1221 (1994) 211-214
104. Ku D.D., Zaleski J.K., Liu S., and Brock T.A. Vascular endothelial growth factor induces EDRF-dependent relaxation in coronary arteries. Am. J. Physiol. 265 (1993) H586-H592
105. Kuhn R., Schwenk F., Aguet M., and Rajewsky K. Inducible gene targeting in mice. Science 269 (1995) 1427-1429
106. Kvanta A., Algvere P.V., Berglin L., and Seregard S. Subfoveal fibrovascular membranes in age-related macular degeneration express vascular endothelial growth factor. Invest. Ophthalmol. Vis. Sci. 37 (1996) 1929-1934
107. Lee J., Gray A., Yuan J., Luoh S.M., Avraham H., and Wood W.I. Vascular endothelial growth factor-related protein: A ligand and specific activator of the tyrosine kinase receptor Flt4. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 1988-1992
108. Leung D.W., Cachianes G., Kuang W.J., Goeddel D.V., and Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246 (1989) 1306-1309
109. Levy A.P., Levy N.S., and Goldberg M.A. Post-transcriptional regulation of vascular endothelial growth factor by hypoxia. J. Biol. Chem. 271 (1996) 2746-2753
110. Levy A.P., Levy N.S., Wegner S., and Goldberg M.A. Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia. J. Biol. Chem. 270 (1995) 13333-13340
111. Li J., Brown L.F., Hibberd M.G., Grossman J.D., Morgan J.P., and Simons M. VEGF, flk-1, and flt-1 expression in a rat myocardial infarction model of angiogenesis. Am. J. Physiol. 270 (1996) H1803-H1811
112. Li J., Perrella M.A., Tsai J.C., Yet S.F., Hsieh C.M., Yoshizumi M., Patterson C., Endego W.O., Zhou F., and Lee M. Induction of vascular endothelial growyh factor gene expression by interleukin-1 beta in rat aortic smooth muscle cells. J. Biol. Chem. 270 (1995) 308-312
113. Liu Y., Cox S.R., Morita T., and Kourembanas S. Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells. Identification of a 5′ enhancer. Circ. Res. 77 (1995) 638-643
114. Lopez P.F., Sippy B.D., Lambert H.M., Thach A.B., and Hinton D.R. Transdifferentiated retinal pigment epithelial cells are immunoreactive for vascular endothelial growth factor in surgically excised age-related macular degeneration-related choroidal neovascular membranes. Invest. Ophthalmol. Vis. Sci. 37 (1996) 855-868
115. Lyttle D.J., Fraser K.M., Flemings S.B., Mercer A.A., and Robinson A.J. Homologs of vascular endothelial growth factor are encoded by the poxvirus orf virus. J. Virology 68 (1994) 84-92
116. Madan A., and Curtin P.T. A 24-base-pair sequence 3′ to the human erythropoietin gene contains a hypoxia-responsive transcriptional enhancer. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 3928-3932
117. Madri J.A., and Sankar S. The biphasic effects of transforming growth factor beta in angiogenesis. In: Bicknell R., Lewis C., and Ferrara N. (Eds). Tumour Angiogenesis (1997), Oxford University Press, Oxford 239-249
118. Maeda K., Chung Y.S., Ogawa Y., Takatsuka S., Kang S.M., Ogawa M., Sawada T., and Sowa M. Prognostic value of vascular endothelial growth factor expression in gastric carcinoma. Cancer 77 (1996) 858-963
119. Maglione D., Guerriero V., Viglietto G., Delli-Bovi P., and Persico M.G. Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 9267-9271
120. Maglione D., Guerriero V., Viglietto G., Ferraro M.G., Aprelikova O., Alitalo K., Del Vecchio S., Lei K.J., Chou J.Y., and Persico M.G. Two alternative mRNAs coding for the angiogenic factor, placenta growth factor (P1GF), are transcribed from a single gene of chromosome 14. Oncogene 8 (1993) 925-931
121. Malecaze F., Clemens S., Simorer-Pinotel V., Mathis A., Chollet P., Favard P., Bayard F., and Plouet J. Detection of vascular endothelial growth factor mRNA and vascular endothelial growth factor-like activity in proliferative diabetic retinopathy. Arch. Ophthal. 112 (1994) 1476-1482
122. Mandriota S.J., Menoud P.A., and Pepper M.S. Transforming growth factor beta 1 down-regulates vascular endothelial growth factor receptor 2/flk-1 expression in vascular endothelial cells. J. Biol. Chem. 271 (1996) 11500-11505
123. Mandriota S.J., Seghezzi G., Vassalli J.D., Ferrara N., Wasi S., Mazzieri R., Mignatti P., and Pepper M.S. Vascular endothelial growth factor increases urokinase receptor expression in vascular endothelial cells. J. Biol. Chem. 270 (1995) 9709-9716
124. Matthews W., Jordan C.T., Gavin M., Jenkins N.A., Copeland N.G., and Lemischka I.R. A receptor tyrosine kinase cDNA isolated from a population of enriched primitive hematopoietic cells and exhibiting close genetic linkage to c-kit. Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 9026-9030
125. Mazure N.M., Chen E.Y., Yeh P., Laderoute K.R., and Giaccia A.J. Oncogenic transformation and hypoxia synergistically act to modulate vascular endothelial growth factor expression. Cancer Res. 56 (1996) 3436-3440
126. McLaren J., Prentice A., Charnock-Jones D.S., and Smith S.K. Vascular endothelial growth factor (VEGF) concentrations are elevated in peritoneal fluid of women with endometriosis. Human Reprod. 11 (1996) 220-223
127. Melder R.J., Koenig G.C., Witwer B.P., Safabakhsh N., Munn L.L., and Jain R.K. During angiogenesis, vascular endothelial growth factor and basic fibroblast growth factor regulate natural killer cell adhesion to tumor endothelium. Nature Med. 2 (1996) 992-997
128. Melnyk O., Shuman M.A., and Kim K.J. Vascular endothelial growth factor promotes tumor dissemination by a mechanism distinct from its effect on primary tumor growth. Cancer-Res. 56 (1996) 921-924
129. Michaelson I.C. The mode of development of the vascular system of the retina with some observations on its significance for certain retinal disorders. Trans. Ophthalmol. Soc. U.K. 68 (1948) 137-180
130. Millauer B., Shawver L.K., Plate K.H., Risau W., and Ullrich A. Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant. Nature 367 (1994) 576-579
131. Millauer B., Wizigmann Voos S., Schnurch H., Martinez R., Moller N.P., Risau W., and Ullrich A. High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 72 (1993) 835-846
132. Miller J.W., Adamis A.P., Shima D.T., D'Amore P.A., Moulton R.S., O'Reilly M.S., Folkman J., Dvorak H.F., Brown L.F., Berse B., Yeo T.-K., and Yeo K.-T. Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model. Am. J. Pathol. 145 (1994) 574-584
133. Minchenko A., Bauer T., Salceda S., and Caro J. Hypoxic stimulation of vascular endothelial growth factor expression in vivo and in vitro. Lab. Invest. 71 (1994) 374-379
134. Monacci W.T., Merrill M.J., and Oldfield E.H. Expression of vascular permeability factor/vascular endothelial growth factor in normal rat tissues. Am. J. Physiol. 264 (1993) C995-C1002
135. Morishita K., Johnson D.E., and Williams L.T. A novel promoter for vascular endothelial growth factor receptor (flt-1) that confers endothelial-specific gene expression. J. Biol. Chem. 270 (1995) 27948-27953
136. Nicosia R., Nicosia S.V., and Smith M. Vascular endothelial growth factor, platelet-derived growth factor and indulin-like growth factor stimulate angiogenesis in vitro. Am. J. Pathol. 145 (1994) 1023-1029
137. O'Reilly M.S., Boehm T., Shing Y., Fukai N., Vasios G., Lane W.S., Flynn E., Birkhead J.R., Olsen B.R., and Folkman J. Endostatin: An endogenous inhibitor of angiogenesis and tumor growth. Cell 88 (1997) 277-285
138. O'Reilly M.S., Holmgren L., Shing Y., Chen C., Rosenthal R.A., Moses M., Lane W.S., Cao Y., Sage E.H., and Folkman J. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79 (1994) 315-328
139. Olk R.J., and Lee C.M. Diabetic Retinopathy: Practical Management (1993), Lippincott, Philadelphia
140. Olofsson B., Pajusola K., Kaipainen A., von Euler G., Joukov V., Saksela O., Orpana A., Pettersson R.F., Alitalo K., and Eriksson U. Vascular endothelial growth factor B, a novel growth factor for endothelial cells. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 2576-2581
141. Olson T.A., Mohanraj D., Carson L.F., and Ramakrishnan S. Vascular permeability factor gene expression in normal and neoplastic human ovaries. Cancer Res. 54 (1994) 276-280
142. Pajusola K., Aprelikova O., Korhonen J., Kaipainen A., Pertovaara L., Alitalo R., and Alitalo K. FLT4 receptor tyrosine kinase contains seven immunoglobulin-like loops and is expressed in multiple human tissues and cell lines. Cancer Res. 52 (1992) 5738-5743
143. Park J.E., Chen H.H., Winer J., Houck K.A., and Ferrara N. Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR. J. Biol. Chem. 269 (1994) 25646-25654
144. Park J.E., Keller H.-A., and Ferrara N. The vascular endothelial growth factor isoforms (VEGF): Differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF. Molec. Biol. Cell 4 (1993) 1317-1326
145. Patterson C., Perrella M.A., Endege W.O., Yoshizumi M., Lee M.E., and Haber E. Downregulation of vascular endothelial growth factor receptors by tumor necrosis factor-alpha in cultured human vascular endothelial cells. J. Clin. Invest. 98 (1996) 490-496
146. Patterson C., Perrella M.A., Hsieh C.M., Yoshizumi M., Lee M.E., and Haber E. Cloning and functional analysis of the promoter for KDR/flk-1, a receptor for vascular endothelial growth factor. J. Biol. Chem. 270 (1995) 23111-23118
147. Patz A. Studies on retinal neovascularization. Invest. Ophthalmol. Vis. Sci. 19 (1980) 1133-1138
148. Pe'er J., Folberg R., Itin A., Gnessin H., Hemo I., and Keshet E. Upregulated expression of vascular endothelial growth factor in proliferative diabetic retinopathy. Br. J. Ophthalmol. 80 (1996) 241-245
149. Pearlman J.D., Hibberd M.G., Chuang M.L., Harada K., Lopez J.J., Gladstone S.R., Friedman M., Sellke F.W., and Simons M. Magnetic resonance mapping demonstrates benefits of VEGF-induced myocardial angiogenesis. Nature Med. 1 (1995) 1085-1089
150. Pekala P., Marlow M., Heuvelman D., and Connolly D. Regulation of hexose transport in aortic endothelial cells by vascular permeability factor and tumor necrosis factor-alpha, but not by insulin. J. Biol. Chem. 265 (1990) 18051-18054
151. Pepper M.S., Ferrara N., Orci L., and Montesano R. Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells. Biochem. Biophys. Res. Commun. 181 (1991) 902-906
152. Pepper M.S., Ferrara N., Orci L., and Montesano R. Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro. Biochem. Biophys. Res. Commun. 189 (1992) 824-831
153. Pertovaara L., Kaipainen A., Mustonen T., Orpana A., Ferrara N., Saksela O., and Alitalo K. Vascular endothelial growth factor is induced in response to transforming growth factor-beta in fibroblastic and epithelial cells. J. Biol. Chem. 269 (1994) 6271-6274
154. Peters K.G., De Vries C., and Williams L.T. Vascular endothelial growth factor receptor expression during embryogenesis and tissue repair suggests a role in endothelial differentiation and blood vessel growth. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 8915-8919
155. Phillips H.S., Armanini M., Stavrou D., Ferrara N., and Westphal M. Intense focal expression of vascular endothelial growth factor mRNA in human intracranial neoplasms: Association with regions of necrosis. Int. J. Oncol. 2 (1993) 913-919
156. Phillips H.S., Hains J., Leung D.W., and Ferrara N. Vascular endothelial growth factor is expressed in rat corpus luteum. Endocrinology 127 (1990) 965-967
157. Pierce E.A., Avery R.L., Foley E.D., Aiello L.P., and Smith L.E. Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 905-909
158. Plate K.H., Breier G., Millauer B., Ullrich A., and Risau W. Up-regulation of vascular endothelial growth factor and its cognate receptors in a rat glioma model of tumor angiogenesis. Cancer Res. 53 (1993) 5822-5827
159. Plate K.H., Breier G., Weich H.A., and Risau W. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 359 (1992) 845-848
160. Plouet J., and Moukadiri H.J. Characterization of the receptors for vasculotropin on bovine adrenal cortex-derived capillary endothelial cells. J. Biol. Chem. 265 (1990) 22071-22075
161. Presta L.G., Chen H., O'Connor S.J., Chisholm V., Meng Y.G., Krummen L., Winkler M., and Ferrara N. Humanization of an anti-VEGF monoclonal antibody for the therapy of solid tumors and other disorders. Cancer Res. 57 (1997) 4593-4599
162. Qu H., Nagy J.A., Senger D.R., Dvorak H.F., and Dvorak A.M. Ultrastructural localization of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) to the abluminal plasma membrane and vesiculovacuolar organelles of tumor microvascular endothelium. J. Histochem. Cytochem. 43 (1995) 381-389
163. Quinn T.P., Peters K.G., De Vries C., Ferrara N., and Williams L.T. Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 7533-7537
164. Rak J., Mitsuhashi Y., Bayko L., Filmus J., Shirasawa S., Sasazuki T., and Kerbel R.S. Mutant ras oncogenes upregulate VEGF/VPF expression: Implications for induction and inhibition of tumor angiogenesis. Cancer Res. 55 (1995) 4575-4580
165. Ravindranath N., Little-Ihrig L., Phillips H.S., Ferrara N., and Zeleznik A.J. Vascular endothelial growth factor messenger ribonucleic acid expression in the primate ovary. Endocrinology 131 (1992) 254-260
166. Risau W. Mechanisms of angiogenesis. Nature 386 (1997) 671-674
167. Roberts W.G., and Palade G.E. Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. J. Cell Sci. 108 (1995) 2369-2379
168. Roberts W.G., and Palade G.E. Neovasculature induced by vascular endothelial growth factor is fenestrated. Cancer Res. 57 (1997) 765-772
169. Rosen E.M., and Goldberg I.D. Regulation of angiogenesis by scatter factor. In: Rosen E., and Goldberg I.D. (Eds). Regulation of Angiogenesis (1997), Springer Verlag, Berlin 193-208
170. Sato K., Yamazaki K., Shizume K., Kanaji Y., Obara T., Ohsumi K., Demura H., Yamaguchi S., and Shibuya M. Stimulation by thyroid-stimulating hormone and Grave's immunoglobulin G of vascular endothelial growth factor mRNA expression in human thyroid follicles in vitro and fit mRNA expression in the rat thyroid in vivo. J. Clin. Invest. 96 (1995) 1295-1302
171. Seetharam L., Gotoh N., Maru Y., Neufeld G., Yamaguchi S., and Shibuya M. A unique signal transduction from FLT tyrosine kinase, a receptor for vascular endothelial growth factor VEGF. Oncogene 10 (1995) 135-147
172. Shalaby F., Rossant J., Yamaguchi T.P., Gertsenstein M., Wu X.F., Breitman M.L., and Schuh A.C. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376 (1995) 62-66
173. Shen H., Clauss M., Ryan J., Schmidt A.M., Tijburg P., Borden L., Connolly D., Stern D., and Kao J. Characterization of vascular permeability factor/vascular endothelial growth factor receptors on mononuclear phagocytes. Blood 81 (1993) 2767-2773
174. Shibuya M., Yamaguchi S., Yamane A., Ikeda T., Tojo A., Matsushime H., and Sato M. Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase (fit) closely related to the fms family. Oncogene 8 (1990) 519-527
175. Shifren J.L., Doldi N., Ferrara N., Mesiano S., and Jaffe R.B. In the human fetus, vascular endothelial growth factor is expressed in epithelial cells and myocytes, but not vascular endothelium: Implications for mode of action. J. Clin. Endocrinol. Metab. 79 (1994) 316-322
176. Shifren J.L., Tseng J.F., Zaloudek C.J., Ryan I.P., Meng Y.G., Ferrara N., Jaffe R.B., and Taylor R.N. Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: Implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis J. Clin. Endocrinol. Metab. 81 (1996) 3112-3118
177. Shima D.T., Adamis A.P., Ferrara N., Yeo K.T., Yeo T.K., Allende R., Folkman J., and D'Amore P.A. Hypoxic induction of endothelial cell growth factors in retinal cells: Identification and characterization of vascular endothelial growth factor (VEGF) as the mitogen. Molec. Med. 1 (1995) 182-193
178. Shima D.T., Kuroki M., Deutsch U., Ng Y.S., Adamis A.P., and D'Amore P.A. The mouse gene for vascular endothelial growth factor. Genomic structure, definition of the transcriptional unit, and characterization of transcriptional and post-transcriptional regulatory sequences. J. Biol. Chem. 271 (1996) 3877-3883
179. Shweiki D., Itin A., Neufeld G., Gitay-Goren H., and Keshet E. Patterns of expression of vascular endothelial growth factor (VEGF) and VEGF receptors in mice suggest a role in hormonally-mediated angiogenesis. J. Clin. Invest. 91 (1993) 2235-2243
180. Shweiki D., Itin A., Soffer D., and Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359 (1992) 843-845
181. Siemeister G., Weindel K., Mohrs K., Barleon B., Martiny Baron G., and Marme D. Reversion of deregulated expression of vascular endothelial growth factor in human renal carcinoma cells by von Hippel-Lindau tumor suppressor protein. Cancer Res. 56 (1996) 2299-2301
182. Stone J., Itin A., Alon T., Pe'er J., Gnessin H., Chan Ling T., and Keshet E. Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia. J. Neurosci. 15 (1995) 4738-4747
183. Suri C., Jones P.F., Patan S., Bartunkova S., Maisonpierre P.C., Davis S., Sato T.N., and Yancopoulos G.D. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 87 (1996) 1171-1180
184. Suzuki K., Hayashi N., Miyamoto Y., Yamamoto M., Ohkawa K., Ito Y., Sasaki Y., Yamaguchi Y., Nakase H., Noda K., Enomoto N., Arai K., Yamada Y., Yoshihara H., Tujimura T., Kawano K., Yoshikawa K., and Kamada T. Expression of vascular permeability factor/vascular endothelial growth factor in human hepatocellular carcinoma. Cancer Res. 56 (1996) 3004-3009
185. Takagi H., King G.L., Ferrara N., and Aiello L.P. Hypoxia regulates vascular endothelial growth factor receptor KDR/Flk gene expression through adenosine A2 receptors in retinal capillary endothelial cells. Invest. Ophthalmol. Vis. Sci. 37 (1996) 1311-1321
186. Takeshita S., Tsurumi Y., Couffinahl T., Asahara T., Bauters C., Symes J., Ferrara N., and Isner J.M. Gene transfer of naked DNA encoding for three isoforms of vascular endothelial growth factor stimulates collateral development in vivo. Lab. Invest. 75 (1996) 487-501
187. Takeshita S., Weir L., Chen D., Zheng L.P., Riessen R., Bauters C., Symes J.F., Ferrara N., and Isner J.M. Therapeutic angiogenesis following arterial gene transfer of vascular endothelial growth factor in a rabbit model of hindlimb ischemia. Biochem. Biophys. Res. Commun. 227 (1996) 628-635
188. Takeshita S., Zhung L., Brogi E., Kearney M., Pu L.-Q., Bunting S., Ferrara N., Symes J.F., and Isner J.M. Therapeutic angiogenesis: A single intra-arterial bolus of vascular endothelial growth factor augments collateral vessel formation in a rabbit ischemic hind-limb model. J. Clin. Invest. 93 (1994) 662-670
189. Terman B.I., Carrion M.E., Kovacs E., Rasmussen B.A., Eddy R.L., and Shows T.B. Identification of a new endothelial cell growth factor receptor tyrosine kinase. Oncogene 6 (1991) 1677-1683
190. Terman B.I., Dougher Vermazen M., Carrion M.E., Dimitrov D., Armellino D.C., Gospodarowicz D., and Bohlen P. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochem. Biophys. Res. Commun. 187 (1992) 1579-1586
191. Tischer E., Mitchell R., Hartman T., Silva M., Gospodarowicz D., Fiddes J.C., and Abraham J.A. The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J. Biol. Chem. 266 (1991) 11947-11954
192. Toi M., Kondo S., Suzuki H., Yamamoto Y., Inada K., Imazawa T., Taniguchi T., and Tominaga T. Quantitative analysis of vascular endothelial growth factor in primary breast cancer. Cancer 77 (1996) 1101-1106
193. Tolentino M.J., Miller J.W., Gragoudas E.S., Chatzistefanou K., Ferrara N., and Adamis A.P. Vascular endothelial growth factor is sufficient to produce iris neovascularization and neovascular glaucoma in a nonhuman primate. Arch. Ophthalmol. 114 (1996) 964-970
194. Tuder R.M., Flook B.E., and Voelkel N.F. Increased gene expression for VEGF and the VEGF receptors KDR/Flk and Flt in lungs exposed to acute or to chronic hypoxia. Modulation of gene expression by nitric oxide. J. Clin. Invest. 95 (1995) 1798-1807
195. Unemori E.N., Ferrara N., Bauer E.A., and Amento E.P. Vascular endothelial growth factor induces interstitial collagenase expression in human endothelial cells. J. Cell. Physiol. 153 (1992) 557-562
196. Vaisman N., Gospodarowicz D., and Neufeld G. Characterization of the receptors for vascular endothelial growth factor. J. Biol. Chem. 265 (1990) 19461-19466
197. Viglietto G., Romano A., Maglione D., Rambaldi M., Paoletti I., Lago C.T., Califano D., Monaco C., Mineo A., Santelli G., Manzo G., Botti G., Chiappetta G., and Persico M.G. Neovascularization in human germ cell tumors correlates with a marked increase in the expression of the vascular endothelial growth factor but not the placenta-derived growth factor. Oncogene 13 (1996) 577-587
198. Vincenti V., Cassano C., Rocchi M., and Persico G. Assignment of the vascular endothelial growth factor gene to human chromosome 6p21.3. Circulation 93 (1996) 1493-1495
199. Volm M., Koomagi R., and Mattern J. Prognostic value of vascular endothelial growth factor and its receptor Flt-1 in squamous cell lung cancer. Int. J. Cancer 74 (1997) 64-68
200. Volm M., Koomagi R., Mattern J., and Stammler G. Angiogenic growth factors and their receptors in non-small cell lung carcinomas and their relationships to drug response in vitro. Anticancer Res. 17 (1997) 99-103
201. Walder C.E., Errett C.J., Bunting S., Lindquist P., Ogez J.R., Heinsohn H.G., Ferrara N., and Thomas G.R. Vascular endothelial growth factor augments muscle blood flow and function in a rabbit model of chronic hindlimb ischemia. J. Cardiovasc. Pharmacol 27 (1996) 91-98
202. Waltenberger J., Claesson Welsh L., Siegbahn A., Shibuya M., and Heldin C.H. Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor. J. Biol. Chem. 269 (1994) 26988-26995
203. Wang G.L., and Semenza G.L. Purification and characterization of hypoxia-inducible factor 1. J. Biol. Chem. 270 (1995) 1230-1237
204. Ware J.A., and Simons M. Angiogenesis in ischemic heart disease. Nature Med. 3 (1997) 158-164
205. Warren R.S., Yuan H., Matli M.R., Ferrara N., and Donner D.B. Induction of vascular endothelial growth factor by insulin-like growth factor 1 in colorectal carcinoma. J. Biol. Chem. 271 (1996) 29483-29488
206. Warren R.S., Yuan H., Matli M.R., Gillett N.A., and Ferrara N. Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis. J. Clin. Invest. 95 (1995) 1789-1797
207. Wizigmann Voos S., Breier G., Risau W., and Plate K.H. Up-regulation of vascular endothelial growth factor and its receptors in von Hippel-Lindau disease-associated and sporadic hemangioblastomas. Cancer Res. 55 (1995) 1358-1364
208. Yamaguchi T.P., Dumont D.J., Conlon R.A., Breitman M.L., and Rossant J. Flk-1, an flt-related receptor tyrosine kinase is an early marker for endothelial cell precursors. Development 118 (1993) 489-498
209. Yang R., Thomas G.R., Bunting S., Ko A., Ferrara N., Keyt B., Ross J., and Jin H. Effects of vascular endothelial growth factor on hemodynamics and cardiac performance. J. Cardiovasc. Pharmacol. 27 (1996) 838-844
210. Yoshiji H., Gomez D.E., Shibuya M., and Thorgeirsson U.P. Expression of vascular endothelial growth factor, its receptor, and other angiogenic factors in human breast cancer. Cancer Res. 56 (1996) 2013-2016
211. Yuan F., Chen Y., Dellian M., Safabakhsh N., Ferrara N., and Jain R.K. Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 14765-14770